Publications

Kohler, Maurus et al. “Clinical Relevance of Human Immunodeficiency Virus Low-level Viremia in the Dolutegravir era: Data From the Viral Load Cohort North-East Lesotho (VICONEL).” Open forum infectious diseases vol. 11,2 ofae013. 8 Jan. 2024.

Tschumi, Nadine et al. “Emergence of Acquired Dolutegravir Resistance in Treatment-experienced People With HIV in Lesotho.” Clinical infectious diseases : an official publication of the Infectious Diseases Society of America vol. 79,5 (2024): 1208-1222.

Devendra, Akash et al. “HIV viral suppression in children and adolescents 2 years after transition to dolutegravir: a multicentre cohort study.” AIDS (London, England) vol. 38,7 (2024): 1013-1023.

Tschumi, Nadine et al. “Two-Year Outcomes of Treatment-Experienced Adults After Programmatic Transitioning to Dolutegravir: Longitudinal Data From the VICONEL Human Immunodeficiency Virus Cohort in Lesotho.” Clinical infectious diseases : an official publication of the Infectious Diseases Society of America vol. 77,9 (2023): 1318-1321.

Muhairwe, Josephine A et al. “The Suboptimal Pediatric HIV Viral Load Cascade: Multidistrict Cohort Study Among Children Taking Antiretroviral Therapy in Lesotho, Southern Africa.” The Pediatric infectious disease journal vol. 41,3 (2022): e75-e80.

Glass, Tracy R et al. “The viral load monitoring cascade in a resource-limited setting: A prospective multicentre cohort study after introduction of routine viral load monitoring in rural Lesotho.” PloS one vol. 14,8 e0220337. 28 Aug. 2019.

Publications from projects nested within VICONEL:

DO-REAL:

• Brown, Jennifer A et al. “Viral suppression after transition from nonnucleoside reverse transcriptase inhibitor- to dolutegravir-based antiretroviral therapy: A prospective cohort study in Lesotho (DO-REAL study).” HIV medicine vol. 23,3 (2022): 287-293.

• Brown, Jennifer A et al. “Dolutegravir in real life: Self-reported mental and physical health outcomes after transitioning from efavirenz- to dolutegravir-based antiretroviral therapy in a prospective cohort study in Lesotho.” HIV medicine vol. 24,2 (2023): 153-162.

  Brown, Jennifer A et al. “Seroprofiling of Antibodies Against Endemic Human Coronaviruses and Severe Acute Respiratory Syndrome Coronavirus 2 in a Human Immunodeficiency Virus Cohort in Lesotho: Correlates of Antibody Response and Seropositivity.” The Journal of infectious diseases vol. 228,8 (2023): 1042-1054.

  VITAL:

• Scherrer, Ramona et al. “eHealth supported multi-months dispensing of antiretroviral therapy: a mixed-methods preference assessment in rural Lesotho.” Pilot and feasibility studies vol. 8,1 61. 11 Mar. 2022.

• Tschumi, Nadine et al. “Assessment of a viral load result-triggered automated differentiated service delivery model for people taking ART in Lesotho (the VITAL study): Study protocol of a cluster-randomized trial.” PloS one vol. 17,5 e0268100. 5 May. 2022.

• Harder, Michelle T et al. “Cervical cancer screening delay and associated factors among women with HIV in Lesotho: a mixed-methods study.” BMC women's health vol. 24,1 543. 1 Oct. 2024, doi:10.1186/s12905-024-03382-8